Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care

[1]  A. Levin,et al.  Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  L. C. Ribeiro,et al.  Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution. , 2012, Sao Paulo medical journal = Revista paulista de medicina.

[3]  A. Pickard,et al.  Outcome, toxicity profile and cost analysis of autologous stem cell mobilization , 2011, Bone Marrow Transplantation.

[4]  M. Kersten,et al.  Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment. , 2011, Journal of clinical nursing.

[5]  S. Fernandez,et al.  Delayed administration of filgrastim (G‐CSF) following autologous peripheral blood stem cell transplantation (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G‐CSF , 2010, Pediatric blood & cancer.

[6]  D. Speckhart,et al.  Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM , 2010, Bone Marrow Transplantation.

[7]  P. Kiel,et al.  Peripheral Blood Stem Cell Mobilization Tactics , 2010, The Annals of pharmacotherapy.

[8]  K. Conceição,et al.  NURSE-PATIENT RELATIONSHIP: CARE AS THERAPY RELACIONAMIENTO ENFERMERA/PACIENTE: PERSPECTIVA TERAPÉUTICA DEL CUIDADO , 2010 .

[9]  Josicélia Dumêt Fernandes,et al.  Relacionamento enfermeira/paciente: perspectiva terapêutica do cuidado , 2010 .

[10]  K. Acar,et al.  Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation , 2010, Journal of clinical apheresis.

[11]  H. Einsele,et al.  Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. , 2009, Bone marrow transplantation.

[12]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[13]  L. Castagna,et al.  Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease , 2009, Leukemia & lymphoma.

[14]  D. Chamone,et al.  Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[15]  Alfredo Mendrone Júnior.  Coleta de células progenitoras hematopoéticas de sangue periférico após administração de ciclofosfamida e fator estimulador de colônias de granulócitos (G-CSF): uma análise de 307 pacientes , 2008 .

[16]  J. Styczyński,et al.  Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome , 2007, Infection.

[17]  O. Arslan,et al.  Mobilization of peripheral blood stem cells. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[18]  Joseph D Tariman,et al.  The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursing. , 2007, Clinical journal of oncology nursing.

[19]  E. Montserrat,et al.  Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  W. Kern.  Outpatient management in patients with neutropenia after intensive chemotherapy--is it safe? , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  J. E. Nicolau.  O transplante de medula óssea alogênico de curto período de internação , 2004 .

[22]  E. Schiavone,et al.  Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma. , 2004, The hematology journal : the official journal of the European Haematology Association.

[23]  E. Hacker.  Quantitative measurement of quality of life in adult patients undergoing bone marrow transplant or peripheral blood stem cell transplant: a decade in review. , 2003, Oncology nursing forum.

[24]  A. Mank,et al.  Is there still an indication for nursing patients with prolonged neutropenia in protective isolation?. An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation. , 2003, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[25]  E. Oliva,et al.  Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. , 2002, Haematologica.

[26]  K. Cornetta,et al.  Longitudinal study of adaptation to the stress of bone marrow transplantation. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  S. Cessie,et al.  Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. , 2000, Journal of psychosomatic research.

[28]  D. Dorsky,et al.  Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation , 2000, Bone Marrow Transplantation.

[29]  K. Vedhara,et al.  A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation , 1999, Bone Marrow Transplantation.

[30]  C. Buckner.  Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective. , 1999, Journal of hematotherapy.

[31]  P. Jacobsen,et al.  Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. , 1999, Journal of pain and symptom management.

[32]  S. McCann,et al.  Psychosocial adaptation of patients and families following bone marrow transplantation: a prospective, longitudinal study , 1998, Bone Marrow Transplantation.

[33]  J. Perfect,et al.  Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.